Uluslararası Huzursuz Bacaklar Sendromu Çalışma Grubu Değerlendirme Ölçeğinin Türkçe Versiyonunun Geçerlilik ve Güvenilirliği

Yıl 2019, Cilt: 3 Sayı: 2, 105 - 110, 23.08.2019

Elif Ay Nesrin Helvacı Yılmaz Özge Arıcı Düz Fahriye Feriha Özer

https://doi.org/10.30565/medalanya.453150

Cited By: 7

Öz

Amaç: Bu çalışmanın amacı, Uluslararası Huzursuz Bacaklar Sendromu (HBS) Çalışma Grubu Şiddet Ölçeği’nin Türkçe versiyonunu hazırlayarak geçerlilik ve güvenirliğini araştırmaktır. 

Materyal ve Metod: Çalışmaya toplamda 89 HBS’li birey alındı. Hastalar iki gruba ayrıldı: pilot çalışma grubu (n=20), çalışma grubu (n=69). Türkçe çeviri ve düzenlemeleri yapılan ölçek gruplara uygulandı. 

Sonuç: Ölçeğin faktör yapısını test etmek için yapılan analizde maddelerin iki faktör altında toplandığı ve iki faktörün toplamda varyansın %68,19’unu açıkladığı görülmektedir. Ölçeğin geçerliliği için saptanan KMO (Kaiser-Meyer-Olkin) katsayısı 0.84, Bartlett Küresellik indeksi p<0.005 olarak anlamlı bulundu. Ölçeğin güvenilirliğini belirlemek amacıyla elde edilen Cronbach’s Alpha katsayısı 0.896’dır. 

Tartışma: Bu çalışmada bilimsel ve klinik çalışmalarda sık kullanılan bu ölçeğin Türkçe versiyonu gösterilmiştir. 

Anahtar Kelimeler

Huzursuz bacak sendromu, geçerlilik, güvenirlilik

Validity and Reliability of the Turkish Version of The International Restless Legs Syndrome Study Group Rating Scale

Öz

Aim: The purpose of this study is to prepare the Turkish version of the International Restless Legs Syndrome (RLS) Study Group Rating Scale and to investigate its validity and reliability. 

Materials and Methods: A total of 89 individuals with RLS were included. These subjects were divided into two groups: A pilot study group (n=20) and a study group (n=69). The scale was translated into and adjusted for Turkish was applied to the groups. 

Results: In the analysis conducted to test the factor structure of the scale, it was clearly seen that the items were collected under two factors and that the two factors in total accounted for 68.19% of the variance. The Kaiser-Meyer-Olkin (Kaiser-Meyer-Olkin) coefficient for validity of the scale was 0.84 and Bartlett Sphericity index was significant with p <0.005. The Cronbach's Alpha coefficient, which determined the reliability of the scale, was 0.0896. 

Conclusions: This study demonstrated that the Turkish version of this scale that is frequently used for scientific and clinical trials is valid. 

Anahtar Kelimeler

Restless Legs Syndrome, validity, reliability

Kaynakça

• 1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J.  Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-19.  PMID: 14592341
• 2. Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB; International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. 
• 3. Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004;5(3):293-9. doi: 10.1016/j.sleep.2004.01.004
• 4. Tasdemir M, Erdogan H, Boru UT, Dilaver E, Kumas A. Epidemiology of Restless legs syndrome in Turkish adults on the western Black Sea coast of Turkey. A door to-door study in rural area. Sleep Med. 2010;11(1):82-6. doi: 10.1016/j.sleep.2008.10.008. 
• 5. Erer S, Karli N, Zarifoglu M, Ozcakir A, Yildiz D. The prevalence and clinical features of restless legs syndrome: A door to door population study in Orhangazi, Bursa in Turkey. Neurol India. 2009;57(6):729-33. doi: 10.4103/0028-3886.59467.
• 6. Innes KE, Flack KL, Selfe TK, Kandati S, Agarwal P. Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden. J Clin Sleep Med. 2013;9(10):1065-75. doi: 10.5664/jcsm.3084.
• 7. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C; International Restless Legs Syndrome Study Group. Validation of the International Restless legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-32. PMID: 14592342
• 8. Masuko AH, Carvalho LB, Machado MA, Morais JF, Prado LB, Prado GF. Translation and validation into the Brazilian Portuguese of the restless legs syndrome rating scale of the International Restless Legs Syndrome Study Group. Arq Neuropsiquiatr. 2008;66(4):832-6. PMID: 19099121
• 9. Inoue Y, Oka Y, Kagimura T, Kuroda K, Hirata K. Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting. Psychiatry Clin Neurosci. 2013;67(6):412-9. doi: 10.1111/pcn.12074.
• 10. Shalash AS, Elrassas HH, Monzem MM, Salem HH, Abdel Moneim A, Moustafa RR. Restless legs syndrome in Egyptian medical students using a validated Arabic version of the Restless Legs Syndrome Rating Scale. Sleep Med. 2015;16(12):1528-31. doi: 10.1016/j.sleep.2015.07.032.
• 11. Aksu A, Demirci S, Bara-Jimenez W. Correlation between putative indicators of primary restless legs syndrome severity. Sleep Med. 2007;8(1):84-9. doi: 10.1016/j.sleep.2005.12.001
• 12. Allen RP, Earley CJ 2001. Validation of the Johns Hopkins restless legs severity scale (JHRLSS). Sleep Med. 2001;2(3):239. PMID: 11311687
• 13. Durgin T, Witt EA, Fishman J. The Humanistic and Economic Burden of Restless Legs Syndrome. PLoS One. 2015;10(10):e0140632. doi: 10.1371/journal.pone.0140632. eCollection 2015.
• 14. Barroso-Perez MT, Cubo E, Cordero-Guevara J, Poza-Maure E, Checa-Diez L. Quality of life and associated characteristics of restless legs syndrome in the adult population of Burgos, Spain. Rev Neurol. 2017;65(6):257-62. PMID: 28895999
• 15. Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med. 2013;14(7):675-84.  doi: 10.1016/j.sleep.2013.05.016.